Switching from predictive low glucose suspend to advanced hybrid closed loop control: Effects on glucose control and patient reported outcomes
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Switching from predictive low glucose suspend to advanced hybrid closed loop control: Effects on glucose control and patient reported outcomes
Authors
Keywords
Advanced hybrid closed loop control, Predictive low glucose suspend, Type 1 diabetes, Glucose control, Time in range, Psychological aspects
Journal
DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 185, Issue -, Pages 109784
Publisher
Elsevier BV
Online
2022-02-18
DOI
10.1016/j.diabres.2022.109784
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology
- (2021) Marc D. Breton et al. Diabetes Technology & Therapeutics
- Improved technology satisfaction and sleep quality with Medtronic MiniMed® Advanced Hybrid Closed-Loop delivery compared to predictive low glucose suspend in people with Type 1 Diabetes in a randomized crossover trial
- (2021) Benjamin J. Wheeler et al. ACTA DIABETOLOGICA
- Amelioration of user experiences and glycaemic outcomes with an Advanced Hybrid Closed Loop System in a real-world clinical setting
- (2021) Pilar Isabel Beato-Víbora et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy
- (2020) Julia Fuchs et al. Expert Review of Medical Devices
- Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology
- (2020) Jordan E. Pinsker et al. Diabetes Technology & Therapeutics
- A clinical review of the t:slim X2 insulin pump
- (2020) Cari Berget et al. Expert Opinion on Drug Delivery
- Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial
- (2019) Emanuele Bosi et al. Lancet Diabetes & Endocrinology
- Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
- (2019) Sue A. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review
- (2018) C. Farrington DIABETIC MEDICINE
- Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis
- (2018) Eleni Bekiari et al. BMJ-British Medical Journal
- Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis
- (2018) Eleni Bekiari et al. BMJ-British Medical Journal
- Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial
- (2018) Gregory P. Forlenza et al. DIABETES CARE
- Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials
- (2017) Alanna Weisman et al. Lancet Diabetes & Endocrinology
- Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis
- (2015) Bruce A. Buckingham et al. DIABETES CARE
- Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia
- (2013) Richard M. Bergenstal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Artificial Pancreas: Past, Present, Future
- (2011) Claudio Cobelli et al. DIABETES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now